FIRST-QUARTER HIGHLIGHTS:
- TOTAL REVENUE UP 69.5%
- NET INCOME UP 59.7%; GAAP DILUTED EPS UP 24.8%
- ADJUSTED EBITDA UP 100.0%; ADJUSTED DILUTED EPS UP
40.5%
- MARCUM INTEGRATION ON SCHEDULE
CLEVELAND, April 24,
2025 /PRNewswire/ -- CBIZ, Inc., (NYSE: CBZ)
("CBIZ" or the "Company"), a leading national professional services
advisor, today announced results for the first quarter ended
March 31, 2025.
"CBIZ delivered positive first-quarter results. As we have
demonstrated throughout our history, our operating model enables us
to deliver strong earnings and cash flow in varying business
climates and our first-quarter financial results are consistent
with that history. We are also pleased to report that the
Marcum-related integration work is proceeding on schedule, and we
continue to experience strong employee and client retention rates
and outstanding collaboration within our combined team," said
Jerry Grisko, CBIZ President and
Chief Executive Officer.
For the first quarter of 2025, CBIZ recorded revenue of
$838.0 million, an increase of
$343.7 million, or 69.5%, compared
with $494.3 million reported for
the same period in 2024. Net income was $122.8 million, or $1.91 per diluted share, for the first quarter of
2025, compared with $76.9 million, or
$1.53 per diluted share, for the same
period a year ago.
Adjusted EBITDA for the first quarter of 2025 was $237.6 million, up 100.0%, compared with
$118.8 million for the same period a
year ago. Adjusted net income was $147.2
million, or $2.29 per diluted
share, for the first quarter of 2025, compared with Adjusted net
income of $81.9 million, or
$1.63 per diluted share, for the same
period a year ago. Adjusted net income increased by 79.7%, and
Adjusted earnings per diluted share increased by 40.5%, for the
first quarter of 2025, compared to the same period a year
ago.
The uncertainty in the current economic and geopolitical
environment has already begun to impact non-recurring service
lines, a trend that is expected to continue. Since these services
represent a higher proportion of revenue for the remainder of the
year and given the Company's limited visibility into forecasting
client demand, the Company now expects full-year 2025 revenue to be
within a range of $2.8 billion to
$2.95 billion.
2025 Outlook
The Company expects:
- Total revenue within a range of $2.8
billion to $2.95 billion
- Effective tax rate of approximately 29%
- Weighted average fully diluted share count within a range of
64.5 to 65.0 million shares
- GAAP fully diluted earnings per share to be within a range of
$1.97 to $2.02
- Adjusted fully diluted earnings per share within a range of
$3.60 to $3.65
- Adjusted EBITDA within a range of $450
million to $456 million
Conference Call
CBIZ will host a conference call at 11
a.m. (ET) today to discuss its first-quarter financial
results. The call will be webcast, and an archived replay will be
available at https://cbiz.gcs-web.com/investor-overview.
Participants can register for the conference call at
https://dpregister.com/sreg/10198710/fee4c9dc2a.
About CBIZ
CBIZ, Inc. (NYSE: CBZ) is a leading professional services
advisor to middle-market businesses nationwide. With industry
knowledge and expertise in accounting, tax, advisory, benefits,
insurance, and technology, CBIZ delivers actionable insights to
help clients anticipate what is next and discover new ways to
accelerate growth. CBIZ has more than 10,000 team members across
more than 160 locations in 22 major markets coast to coast. For
more information, visit www.cbiz.com.
Forward-Looking Statements
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended
(the "Securities Act"), and Section 21E of the Securities Exchange
Act of 1934, as amended (the "Exchange Act"). All statements other
than statements of historical fact included in this release,
including, without limitation, our "2025 Outlook," regarding our
financial position, business strategy and plans and objectives for
future performance are forward-looking statements. You can identify
these statements by the fact that they do not relate strictly to
historical or current facts. Forward-looking statements are
commonly identified by the use of such terms and phrases as "will,"
"could," "can," "may," "strive," "hope," "intend," "believe,"
"estimate," "continue," "plan," "expect," "project," "anticipate,"
"outlook," "foreseeable future," "seek" and words or phrases of
similar import in connection with any discussion of future
operating or financial performance. In particular, these include
statements relating to future actions, future performance or
results of current and anticipated services, sales efforts,
expenses, and financial results.
From time to time, we may also provide oral or written
forward-looking statements in other materials we release to the
public. Any or all of our forward-looking statements in this
release and in any other public statements that we make, are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those projected. Such risks and
uncertainties include, but are not limited to: payments on accounts
receivable may be slower than expected, or amounts due on
receivables or notes may not be fully collectible; our business
could be adversely affected if Marcum does not perform to our
expectations or we underestimate the liabilities we have assumed;
we are dependent on the services of our executive officers, and
other key employees, the loss of whom may have a material adverse
effect on our business, financial condition and results of
operations; restrictions imposed by independence requirements and
conflict of interest rules, as well as the nature and terms of our
current administrative service agreements, limit our ability to
provide services to clients of the attest firms with which we have
contractual relationships and the ability of such attest firms to
provide attestation services to our clients; our goodwill and other
intangible assets could become impaired, which could lead to
material non-cash charges against earnings and a material impact on
our results of operations and financial condition; certain
liabilities resulting from acquisitions are estimated and could
lead to a material impact on our results of operations; we may fail
to realize the anticipated benefits of acquisitions, or they may
prove disruptive and could result in the combined business failing
to meet our expectations; recent Securities & Exchange
Commission ("SEC") and Public Company Accounting Oversight Board
sanctions against Marcum may adversely impact our performance and
reputation; if we are unable to implement and maintain effective
internal control over financial reporting following the
Transaction, we may fail to prevent or detect material
misstatements in our financial statements, in which case investors
could lose confidence in the accuracy and completeness of our
financial reports and the market price of our common stock may
decline; we may not be able to acquire and finance additional
businesses, which could limit our ability to pursue our business
strategy; we will incur transaction, integration, and restructuring
costs in connection with our acquisition program; governmental
regulations and interpretations are subject to changes, which could
have a material adverse effect on our financial condition; changes
in the United States healthcare
environment, including new healthcare legislation, may adversely
affect the revenue and margins in our healthcare benefit business;
we are subject to risks relating to processing customer
transactions for our payroll and other transaction processing
businesses; cyberattacks or other security breaches involving our
computer systems or the systems of one or more of our vendors could
materially and adversely affect our business; we are subject to
risk as it relates to software that we license from third parties;
we are reliant on information processing systems and any failure or
disruptions of these systems could have a material adverse effect
on our business, financial condition and results of operations; we
could be held liable for errors and omissions; the business
services industry is competitive and fragmented, if we are unable
to compete effectively, our business, financial condition and
results of operations could be negatively impacted; given our
levels of share-based compensation, our tax rate may vary
significantly depending on our stock price; rapid technological
changes could significantly impact our competitive position, client
relationships and operating results and our ability to realize the
anticipated benefits of the Transaction; climate change legislation
or regulations restricting emissions of greenhouse gases could
result in increased operating costs; the widespread outbreak of a
communicable illness or any other public health crisis could
adversely affect our business, financial condition and results of
operations; we require a significant amount of cash for interest
payments on our debt and to expand our business as planned; terms
of our amended and restated credit agreement (the "2024 Credit
Facilities") providing for $2.0
billion in senior secured credit facilities, consisting of a
$1.4 billion term loan and
$600.0 million revolving credit
facility, could adversely affect our ability to run our business
and/or reduce stockholder returns; our failure to satisfy covenants
in our debt instruments could cause a default under those
instruments; our increased leverage following the Transaction may
adversely impact our business; we may be more sensitive to revenue
fluctuations than other companies, which could result in
fluctuations in the market price of our common stock; the
significant number of shares issuable as the stock consideration in
the Transaction may adversely impact our stock price; the future
issuance of additional shares could adversely affect the price of
our common stock; there is volatility in our stock price; and the
price of our common stock could be adversely impacted if we do not
perform to expectations following the Transaction.
Such forward-looking statements can be affected by inaccurate
assumptions we might make or by known or unknown risks and
uncertainties. Should one or more of these risks materialize, or
should the underlying assumptions prove incorrect, actual results
may vary materially from those anticipated, estimated, projected or
implied.
Consequently, no forward-looking statement can be guaranteed. A
more detailed description of risk factors may be found in our
periodic filings with the SEC, including in "Item 1A. Risk Factors"
of our Annual Report on Form 10-K for the year ended December 31, 2024. All forward-looking statements
made in this release are made only as of the date hereof, and we
undertake no obligation to publicly update any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as required by law. You are advised, however,
to consult any further disclosures we make on related subjects in
the current, quarterly, periodic and annual reports we file with
the SEC.
Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are
prepared and presented in accordance with GAAP, we also present
Adjusted Net Income (Loss), Adjusted Diluted Earnings Per Share
("EPS"), and Adjusted EBITDA, which are non-GAAP measures. These
non-GAAP measures are adjusted to exclude the impact of the
Transaction, integration costs, amortization of acquired intangible
assets, and other significant non-operating related gains and
losses management does not consider ongoing in nature.
The presentation of non-GAAP financial information is not
intended to be considered in isolation or as a substitute for, or
superior to, the financial information prepared and presented in
accordance with GAAP. We use these non-GAAP financial measures for
financial and operational decision-making, and to evaluate results
relative to employee compensation targets. We believe that these
non-GAAP financial measures provide meaningful supplemental
information to stockholders, debt holders, and other interested
parties in assessing our performance. These non-GAAP financial
measures also facilitate management's internal comparisons to our
historical performance by excluding significant acquisition
expenses, certain one-time non-recurring items, and gains and
losses that management does not consider ongoing in nature. We
believe these non-GAAP financial measures are useful to investors
both because (1) they allow for greater transparency with respect
to key measures used by management in its financial and operational
decision-making and (2) they are used by our stockholders and
analyst community to determine the health of our business.
Management provides specific information regarding the GAAP
amounts excluded from or included in these non-GAAP financial
measures. Additionally, management provides reconciliations of
these non-GAAP financial measures to their most comparable
financial measures in accordance with GAAP. Please see the sections
captioned "GAAP Reconciliation" within the Appendix for the
reconciliations.
CBIZ,
INC. FINANCIAL HIGHLIGHTS (UNAUDITED) THREE
MONTHS ENDED MARCH 31, 2025 AND 2024 (In thousands,
except percentages and per share data)
|
|
|
|
Three Months Ended March 31,
|
|
|
2025
|
|
%
|
|
2024
|
|
%
|
Revenue
|
|
$
838,014
|
|
100.0 %
|
|
$
494,297
|
|
100.0 %
|
Operating expenses
(1)
|
|
609,912
|
|
72.8
|
|
376,485
|
|
76.2
|
Gross margin
|
|
228,102
|
|
27.2
|
|
117,812
|
|
23.8
|
Corporate general and
administrative expenses (1)
|
|
28,070
|
|
3.3
|
|
18,711
|
|
3.8
|
Operating income
|
|
200,032
|
|
23.9
|
|
99,101
|
|
20.0
|
Other (expense)
income:
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
(25,156)
|
|
(3.0)
|
|
(4,511)
|
|
(0.9)
|
Other income
(expense), net (1) (2)
|
|
(1,966)
|
|
(0.2)
|
|
9,424
|
|
1.9
|
Total other income
(expense), net
|
|
(27,122)
|
|
(3.2)
|
|
4,913
|
|
1.0
|
Income before income tax
expense
|
|
172,910
|
|
20.7
|
|
104,014
|
|
21.0
|
Income tax
expense
|
|
50,137
|
|
|
|
27,130
|
|
|
Net income
|
|
122,773
|
|
14.7
|
|
76,884
|
|
15.6
|
Loss from operations of
discontinued businesses, net of tax
|
|
—
|
|
|
|
—
|
|
|
Net income
|
|
$
122,773
|
|
14.7 %
|
|
$
76,884
|
|
15.6 %
|
|
|
|
|
|
|
|
|
|
Diluted income per share:
|
|
|
|
|
|
|
|
|
Continuing
operations
|
|
$ 1.91
|
|
|
|
$ 1.53
|
|
|
Diluted earnings per share
|
|
$
1.91
|
|
|
|
$
1.53
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted
average common shares outstanding
|
|
64,142
|
|
|
|
50,221
|
|
|
Other data:
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
(3)
|
|
$ 237,620
|
|
|
|
$ 118,830
|
|
|
Adjusted Diluted EPS
(3)
|
|
$ 2.29
|
|
|
|
$ 1.63
|
|
|
|
|
(1)
|
CBIZ sponsors a
deferred compensation plan, under which a CBIZ employee's
compensation deferral is held in a rabbi trust and invested as
directed by the employee. Income and expenses related to the
deferred compensation plan are included in "Operating expenses" and
"Corporate general and administrative expenses," and are directly
offset by deferred compensation gains or losses in "Other income
(expense), net." The deferred compensation plan has no impact on
"Income before income tax expense."
|
|
|
|
Income and expenses
related to the deferred compensation plan for the three months
ended March 31, 2025, and 2024, are as follows (in
thousands):
|
|
|
|
|
Three Months Ended
March 31,
|
|
|
|
2025
|
|
% of
Revenue
|
|
2024
|
|
% of
Revenue
|
|
Operating (income)
expenses
|
|
$ (2,432)
|
|
(0.3) %
|
|
$
8,576
|
|
1.7 %
|
|
Corporate general &
administrative (income) expenses
|
|
(119)
|
|
— %
|
|
1,057
|
|
0.2 %
|
|
Other (expenses)
income, net
|
|
(2,551)
|
|
(0.3) %
|
|
9,633
|
|
1.9 %
|
|
|
|
|
|
|
|
|
|
|
|
Excluding the impact of
the above-mentioned income and expenses related to the deferred
compensation plan, the operating
results for the three months ended March 31, 2025, and 2024, are as
follows (in thousands):
|
|
|
|
|
Three Months Ended
March 31,
|
|
|
2025
|
|
2024
|
|
|
As
Reported
|
|
Deferred
Compensation
Plan
|
|
Adjusted
|
|
% of
Revenue
|
|
As
Reported
|
|
Deferred
Compensation
Plan
|
|
Adjusted
|
|
% of
Revenue
|
|
Gross margin
|
$ 228,102
|
|
$ (2,432)
|
|
$ 225,670
|
|
26.9 %
|
|
$ 117,812
|
|
$
8,576
|
|
$ 126,388
|
|
25.6 %
|
|
Operating
income
|
200,032
|
|
(2,551)
|
|
197,481
|
|
23.6 %
|
|
99,101
|
|
9,633
|
|
108,734
|
|
22.0 %
|
|
Other income (expense),
net
|
(1,966)
|
|
2,551
|
|
585
|
|
0.1 %
|
|
9,424
|
|
(9,633)
|
|
(209)
|
|
— %
|
|
Income before income
tax expense
|
172,910
|
|
—
|
|
172,910
|
|
20.7 %
|
|
104,014
|
|
—
|
|
104,014
|
|
21.0 %
|
|
|
(2)
|
Included in "Other
income (expense), net" for the three months ended March 31, 2025,
and 2024, is expense of $0.5 million and $0.4 million,
respectively, related to net changes in the fair value of
contingent consideration related to CBIZ's prior
acquisitions.
|
(3)
|
Refer to the schedules
reconciling Adjusted Diluted EPS and Adjusted EBITDA to the most
directly comparable GAAP financial measures at the end of this
release, and for additional information as to the usefulness of the
non-GAAP financial measures to stockholders and
investors.
|
CBIZ,
INC. FINANCIAL HIGHLIGHTS (UNAUDITED) SELECT
SEGMENT DATA (In thousands)
|
|
|
|
Three Months Ended
March 31,
|
|
|
2025
|
|
2024
|
Revenue
|
|
|
|
|
Financial
Services
|
|
$
713,661
|
|
$
372,630
|
Benefits and Insurance
Services
|
|
112,976
|
|
108,408
|
National
Practices
|
|
11,377
|
|
13,259
|
Total
|
|
$
838,014
|
|
$
494,297
|
|
|
|
|
|
Gross
Margin
|
|
|
|
|
Financial
Services
|
|
$
203,168
|
|
$
107,069
|
Benefits and Insurance
Services
|
|
27,618
|
|
24,771
|
National
Practices
|
|
1,112
|
|
1,326
|
Operating expenses -
unallocated (1):
|
|
|
|
|
Other
expense
|
|
(6,228)
|
|
(6,778)
|
Deferred
compensation
|
|
2,432
|
|
(8,576)
|
Total
|
|
$
228,102
|
|
$
117,812
|
|
|
(1)
|
Represents operating
expenses not directly allocated to individual businesses, including
stock-based compensation, consolidation and integration charges,
and certain advertising expenses. "Operating expenses -
unallocated" also includes gains or losses attributable to the
assets held in a rabbi trust associated with the Company's deferred
compensation plan. These gains or losses do not impact "Income
before income tax expense" as they are directly offset by the same
adjustment to "Other income (expense), net" in the Consolidated
Statements of Comprehensive Income. Net gains or losses recognized
from adjustments to the fair value of the assets held in the rabbi
trust are recorded as compensation expense (income) in "Operating
expenses" and "Corporate, general and administrative expenses," and
offset in "Other income (expense), net."
|
CBIZ,
INC. SELECT CASH FLOW DATA (UNAUDITED) (In
thousands)
|
|
|
|
Three Months Ended
March 31,
|
|
|
2025
|
|
2024
|
Net
income
|
|
$
122,773
|
|
$
76,884
|
Adjustments to
reconcile net income to net cash provided by operating
activities:
|
|
|
|
|
Depreciation and
amortization expense
|
|
24,791
|
|
9,468
|
Bad debt expense, net
of recoveries
|
|
417
|
|
550
|
Adjustments to
contingent earnout liability, net
|
|
502
|
|
434
|
Stock-based
compensation expense
|
|
5,639
|
|
2,638
|
Other noncash
adjustments
|
|
5,329
|
|
2,207
|
Net income, after
adjustments to reconcile net income to net cash provided by
operating activities
|
|
159,451
|
|
92,181
|
Changes in assets and
liabilities, net of acquisitions and divestitures
|
|
(247,717)
|
|
(155,901)
|
Net cash used in
operating activities
|
|
(88,266)
|
|
(63,720)
|
Net cash used in
investing activities
|
|
(4,961)
|
|
(28,702)
|
Net cash provided by
financing activities
|
|
55,363
|
|
71,188
|
Net decrease in
cash, cash equivalents and restricted cash
|
|
(37,864)
|
|
(21,234)
|
Cash, cash equivalents
and restricted cash at beginning of year
|
|
$
187,170
|
|
$
157,148
|
Cash, cash
equivalents and restricted cash at end of period
|
|
$
149,306
|
|
$
135,914
|
|
|
|
|
|
Reconciliation of
cash, cash equivalents and restricted cash to the consolidated
balance sheet:
|
Cash and cash
equivalents
|
|
$
8,850
|
|
$
1,402
|
Restricted
cash
|
|
40,777
|
|
27,740
|
Cash equivalents
included in funds held for clients
|
|
99,679
|
|
106,772
|
Total cash, cash
equivalents and restricted cash
|
|
$
149,306
|
|
$
135,914
|
CBIZ,
INC. SELECT FINANCIAL DATA AND RATIOS
(UNAUDITED) (In thousands)
|
|
|
|
March 31,
2025
|
|
December 31,
2024
|
Cash and cash
equivalents
|
|
$
8,850
|
|
$
13,826
|
Restricted
cash
|
|
40,777
|
|
38,661
|
Accounts receivable,
net
|
|
735,426
|
|
534,858
|
Other current
assets
|
|
76,847
|
|
72,528
|
Current assets before
funds held for clients
|
|
861,900
|
|
659,873
|
Funds held for
clients
|
|
140,932
|
|
175,853
|
Goodwill and other
intangible assets, net
|
|
2,906,525
|
|
2,945,470
|
|
|
|
|
|
Total
assets
|
|
4,585,498
|
|
4,470,883
|
|
|
|
|
|
Current liabilities
before client fund obligations, excluding short-term
debt
|
|
452,970
|
|
463,697
|
Client fund
obligations
|
|
140,867
|
|
175,928
|
Total short-term debt,
net
|
|
66,226
|
|
66,177
|
Total long-term debt,
net
|
|
1,462,504
|
|
1,333,755
|
|
|
|
|
|
Total
liabilities
|
|
2,670,797
|
|
2,690,900
|
|
|
|
|
|
Treasury
stock
|
|
(918,327)
|
|
(910,601)
|
|
|
|
|
|
Total stockholders'
equity
|
|
1,914,701
|
|
1,779,983
|
|
|
|
|
|
Debt to
equity
|
|
79.8 %
|
|
78.6 %
|
Days sales outstanding
(DSO) (1)
|
|
96
|
|
73
|
|
|
|
|
|
Shares
outstanding
|
|
54,089
|
|
50,198
|
Basic weighted average
common shares outstanding
|
|
63,843
|
|
52,375
|
Diluted weighted
average common shares outstanding
|
|
64,142
|
|
52,661
|
|
|
(1)
|
DSO is provided for
continuing operations and represents accounts receivable, net, at
the end of the period, divided by trailing twelve-months daily
revenue. The Company has included DSO data because such data is
commonly used as a performance measure by analysts and investors
and as a measure of the Company's ability to collect on receivables
in a timely manner. DSO should not be regarded as an alternative or
replacement to any measurement of performance under GAAP. DSO on
March 31, 2024, was 101.
|
CBIZ,
INC. GAAP RECONCILIATION Net Income (Loss) and
Diluted Earnings Per Share ("EPS") to Adjusted Net Income (Loss),
Adjusted Diluted EPS and Adjusted EBITDA(1) (Unaudited.
Amounts in thousands, except per share data)
|
|
|
Three Months Ended
March 31, 2025
|
|
Financial
Services
|
|
Benefits and
Insurance
Services
|
|
National
Practices
|
|
Corporate &
Other
|
|
Consolidated
|
|
EPS
|
Net income
(loss)
|
$
203,353
|
|
$
27,945
|
|
$
1,112
|
|
$
(109,637)
|
|
$
122,773
|
|
$ 1.91
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
Integration costs
related to acquisitions (2)
|
4,900
|
|
156
|
|
—
|
|
10,636
|
|
15,692
|
|
0.25
|
Amortization of
acquired intangible
assets
|
16,890
|
|
1,776
|
|
—
|
|
—
|
|
18,666
|
|
0.29
|
Income tax effect
related to adjustments
|
—
|
|
—
|
|
—
|
|
(9,964)
|
|
(9,964)
|
|
(0.16)
|
Adjusted net income
(loss)
|
$
225,143
|
|
$
29,877
|
|
$
1,112
|
|
$
(108,965)
|
|
$
147,167
|
|
$ 2.29
|
Interest
expense
|
—
|
|
—
|
|
—
|
|
25,156
|
|
25,156
|
|
|
Income tax
expense
|
—
|
|
—
|
|
—
|
|
50,137
|
|
50,137
|
|
|
Tax effect related to
the adjustments above
|
—
|
|
—
|
|
—
|
|
9,964
|
|
9,964
|
|
|
Depreciation
(3)
|
3,557
|
|
549
|
|
1
|
|
1,089
|
|
5,196
|
|
|
Adjusted
EBITDA
|
$
228,700
|
|
$
30,426
|
|
$
1,113
|
|
$
(22,619)
|
|
$
237,620
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31, 2024
|
|
Financial
Services
|
|
Benefits and
Insurance
Services
|
|
National
Practices
|
|
Corporate &
Other
|
|
Consolidated
|
|
EPS
|
Net income
(loss)
|
$
107,155
|
|
$
24,815
|
|
$
1,326
|
|
$
(56,412)
|
|
$ 76,884
|
|
$ 1.53
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
Integration costs
related to acquisitions (2)
|
95
|
|
—
|
|
—
|
|
487
|
|
582
|
|
0.01
|
Amortization of
acquired intangible
assets
|
3,895
|
|
2,050
|
|
—
|
|
—
|
|
5,945
|
|
0.12
|
Facility optimization
costs (4)
|
255
|
|
—
|
|
—
|
|
—
|
|
255
|
|
0.01
|
Income tax effect
related to adjustments
|
—
|
|
—
|
|
—
|
|
(1,769)
|
|
(1,769)
|
|
(0.04)
|
Adjusted net income
(loss)
|
$
111,400
|
|
$
26,865
|
|
$
1,326
|
|
$
(57,694)
|
|
$ 81,897
|
|
$ 1.63
|
Interest
expense
|
—
|
|
—
|
|
—
|
|
4,511
|
|
4,511
|
|
|
Income tax
expense
|
—
|
|
—
|
|
—
|
|
27,130
|
|
27,130
|
|
|
Tax effect related to
the adjustments above
|
—
|
|
—
|
|
—
|
|
1,769
|
|
1,769
|
|
|
Depreciation
|
1,797
|
|
590
|
|
9
|
|
1,127
|
|
3,523
|
|
|
Adjusted
EBITDA
|
$
113,197
|
|
$
27,455
|
|
$
1,335
|
|
$
(23,157)
|
|
$
118,830
|
|
|
|
|
(1)
|
This table reconciles
Adjusted net income (loss), Adjusted diluted EPS, and Adjusted
EBITDA to the most directly comparable GAAP financial measures.
Adjusted net income (loss), Adjusted diluted EPS, and Adjusted
EBITDA exclude the impact of Marcum acquisition and other
significant non-operating related gains and losses that management
does not consider on-going in nature. Please refer to the 'Non-GAAP
Financial Measures' section for further management
discussion.
|
(2)
|
These costs include,
but are not limited to, certain consulting, technology, personnel,
as well as other integration costs related to acquisitions. Amounts
reported for 2025 relate to the costs associated with the
acquisition of Marcum, and amounts reported in 2024 relate to the
costs associated with the acquisitions of Erickson, Brown &
Kloster, LLC and CompuData, Inc.
|
(3)
|
Depreciation expense
reported for 2025 excluded $0.9 million of depreciation expense
reported as "Integration costs related to acquisitions" above. The
accelerated depreciation was associated with certain technology
assets from the acquisition of Marcum.
|
(4)
|
These costs related to
incremental non-recurring lease expenses incurred as a result of
CBIZ's real estate optimization efforts.
|
CBIZ,
INC. GAAP RECONCILIATION Full Year 2025 Net
Income and Diluted Earnings Per Share ("EPS") to Adjusted Net
Income, Adjusted Diluted
EPS, and Adjusted EBITDA Guidance
|
|
|
Full Year 2025
Guidance
|
|
(Amounts in millions
except per share data)
|
|
Low
|
|
High
|
|
Amounts
|
|
EPS
|
|
Amounts
|
|
EPS
|
GAAP Net
Income
|
$
127.9
|
|
$
1.97
|
|
$
131.1
|
|
$
2.02
|
Amortization of
acquired intangible assets (1)
|
75.1
|
|
1.15
|
|
75.1
|
|
1.15
|
Integration costs
related to acquisitions (2)
|
75.0
|
|
1.15
|
|
75.0
|
|
1.15
|
Income tax effect
related to adjustments
|
(43.5)
|
|
(0.67)
|
|
(43.5)
|
|
(0.67)
|
Adjusted Net
Income
|
$
234.5
|
|
$
3.60
|
|
$
237.7
|
|
$
3.65
|
Depreciation
|
22.1
|
|
|
|
22.1
|
|
|
Interest
expense
|
99.3
|
|
|
|
99.3
|
|
|
Income tax expense
included the tax effect related to
the adjustments above
|
94.5
|
|
|
|
97.1
|
|
|
Adjusted
EBITDA
|
$
450.4
|
|
|
|
$
456.2
|
|
|
|
|
(1)
|
These costs represent
the amortization of the intangible assets, such as client lists,
recognized as a result of applying Accounting Standards
Codification Topic 850, Business Combinations. The amount of
amortization expense recorded in each period is significantly
affected by the size and timing of our acquisitions.
|
(2)
|
These costs include,
but are not limited to, certain consulting, technology, personnel,
as well as other operating and general administrative costs
associated with the integration of Marcum acquisition.
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cbiz-reports-first-quarter-2025-results-302436593.html
SOURCE CBIZ, Inc.